Recombinant human monoclonal antibody (bNAbs) clinical trials

Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control

This study looks at new antibody treatments for people recently diagnosed with HIV. It compares standard HIV medication alone to standard medication plus special antibodies to see if the antibodies help control the virus better when treatment is paused later on.